What is Optel?
Optel, Inc. operates at the intersection of advanced opto-electronic engineering and medical device manufacturing. By leveraging over a century of institutional knowledge in product design, the company provides a robust framework for clients seeking to bridge the gap between conceptual innovation and market-ready production. Their operational model is deeply rooted in strict adherence to global regulatory standards, including FDA and ISO certifications, which mitigates risk for partners in highly regulated industries. From rapid prototyping to high-volume manufacturing, Optel offers a comprehensive suite of services designed to streamline the product development lifecycle and ensure technical precision in every custom system delivered.
How much funding has Optel raised?
Optel has raised a total of $134K across 1 funding round:
Debt
$134K
Debt (2021): $134K with participation from PPP
Key Investors in Optel
PPP
Public-Private Partnership
What's next for Optel?
With the infusion of this latest capital, Optel is well-positioned to accelerate its manufacturing capabilities and expand its footprint in the medical device market. The strategic focus will likely shift toward enhancing automated production lines and deepening its engineering bench to support increasingly complex client requirements. By maintaining its commitment to regulatory excellence and technical agility, Optel is poised to capture additional market share, effectively leveraging its historical expertise to drive future-proof solutions in the rapidly evolving opto-electronic landscape.
See full Optel company page
